Janusz Jankowski

Janusz Jankowski

Auto-generated profile, based on publicly available information

Janusz Jankowski

National Institute for Health and Care Excellence, UK

Research Focus & Metrics

Academic Career Length

37Years (1990-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
28 October 2013 in Gut
Verified
Journal Article
Open access
PDF file
RFRebecca C Fitzgerald
Rebecca C Fitzgerald
MPMassimiliano di Pietro
Massimiliano di Pietro
KRKrish Ragunath
Krish Ragunath
YAYeng Ang
Yeng Ang
JKJin-Yong Kang
Jin-Yong Kang
JCJohn de Caestecker
John de Caestecker
These guidelines provide a practical and evidence-based resource for the management of patients with Barrett's oesophagus and related early neoplasia. The Appraisal of Guidelines for Research and Evaluation (AGREE II) instrument was followed to provide a methodological strategy for the guideline development. A systematic review of the literature was performed for English language articles published up until December 2012 in order to address controversial issues in Barrett's oesophagus including definition, screening and diagnosis, surveillance, pathological grading for dysplasia, management of dysplasia, and early cancer including training requirements. The rigour and quality of the studies was evaluated using the SIGN checklist system. Recommendations on each topic were scored by each author using a five-tier system (A+, strong agreement, to D+, strongly disagree). Statements that failed to reach substantial agreement among authors, defined as >80% agreement (A or A+), were revisited and modified until substantial agreement (>80%) was reached. In formulating these guidelines, we took into consideration benefits and risks for the population and national health system, as well as patient perspectives. For the first time, we have suggested stratification of patients according to their estimated cancer risk based on clinical and histopathological criteria. In order to improve communication between clinicians, we recommend the use of minimum datasets for reporting endoscopic and pathological findings. We advocate endoscopic therapy for high-grade dysplasia and early cancer, which should be performed in high-volume centres. We hope that these guidelines will standardise and improve management for patients with Barrett's oesophagus and related neoplasia.

1 November 2006 in Gastroenterology
Verified
Journal Article
Closed access
PDF file
PSPrateek Sharma
Prateek Sharma
JDJohn Dent
John Dent
David ArmstrongDavid Armstrong
David Armstrong
JBJacques J.G.H.M. Bergman
Jacques J.G.H.M. Bergman
LGLiebwin Gossner
Liebwin Gossner
MVMichael Vieth
Michael Vieth

10 July 2011 in Nature Genetics
Verified
Journal Article
Closed access
PDF file
DEDavid M. Evans
David M. Evans
CSChris C A Spencer
Chris C A Spencer
JPJennifer J Pointon
Jennifer J Pointon
ZSZhan Su
Zhan Su
DHDavid Harvey
David Harvey
PDPeter Donnelly
Peter Donnelly

1 May 2009 in The Lancet Oncology
Verified
Journal Article
Closed access
JCJack Cuzick
Jack Cuzick
FOFlorian Otto
Florian Otto
JBJohn A Baron
John A Baron
PBPowel H Brown
Powel H Brown
John BurnJohn Burn
John Burn
MTMichael Thun
Michael Thun

24 June 2011 in Gut
Verified
Journal Article
Open access
PDF file
WAWilliam H Allum
William H Allum
JBJane M Blazeby
Jane M Blazeby
SGS Michael Griffin
S Michael Griffin
DCDavid Cunningham
David Cunningham
JJJ. A. Jankowski
J. A. Jankowski
RWRachel Wong
Rachel Wong
The original guidelines described the management of oesophageal and gastric cancer within existing practice. This paper updates the guidance to include new evidence and to embed it within the framework of the current UK National Health Service (NHS) Cancer Plan.4 The revised guidelines are informed by reviews of the literature and collation of evidence by expert contributors.5 The key recommendations are listed. The sections of the guidelines are broadly the same layout as the earlier version, with some evidence provided in detail to describe areas of development and to support the changes to the recommendations. The editorial group (WHA, JMB, DC, JAJ, SMG and RW) have edited the individual sections, and the final draft was submitted to independent expert review and modified. The strength of the evidence was classified guided by standard guidelines.6

1 July 2004 in Gastroenterology
Verified
Journal Article
Closed access
PDF file
PSPrateek Sharma
Prateek Sharma
KMKenneth McQuaid
Kenneth McQuaid
JDJohn Dent
John Dent
MFM.BRian Fennerty
M.BRian Fennerty
RSRichard Sampliner
Richard Sampliner
WWWilfred Weinstein
Wilfred Weinstein